Amicus To See If Its Fabry Drug Galafold Can Benefit From Mis-Diagnosed MS

Rare disease specialist Amicus Therapeutics' lead product Galafold has recently launched with early success and the company's president tells Scrip further momentum could come from better Fabry disease diagnosis.